ArriVent BioPharma, Inc. Common Stock AVBP
$15.09
-46.98%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-163,735,000
- Net Margin
- —
- Return on Equity
- -44.63%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 3.83
- Price / Sales
- —
Over the trailing twelve months, ArriVent BioPharma, Inc. Common Stock generated revenue of — and net income of $-163,735,000.
Key Stats
- Last Close
- $15.09
- Market Cap
- $1.40 billion
- 52-Week Range
- $11.36 – $35.83
- Average Volume
- 1.24 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.